Laura Jimenez-Sanchez
Overview
Explore the profile of Laura Jimenez-Sanchez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
397
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jimenez-Sanchez L, Wong T, Ouro A
Front Synaptic Neurosci
. 2024 Sep;
16:1470791.
PMID: 39262896
No abstract available.
2.
Vazquez-Lorente H, Herrera-Quintana L, Jimenez-Sanchez L, Fernandez-Perea B, Plaza-Diaz J
Antioxidants (Basel)
. 2024 Aug;
13(8).
PMID: 39199241
Evidence is increasing that vitamin D and CYP11A1-derived vitamin D, tachysterol, and lumisterol metabolites play a significant antioxidant role beyond its classical functions in bone health and calcium metabolism. Several...
3.
Diaz-Casado M, Gonzalez-Garcia P, Lopez-Herrador S, Hidalgo-Gutierrez A, Jimenez-Sanchez L, Barriocanal-Casado E, et al.
Biochim Biophys Acta Mol Basis Dis
. 2024 Jun;
1870(7):167283.
PMID: 38851305
Obesity represents a significant health challenge, intricately linked to conditions such as type II diabetes, metabolic syndrome, and hepatic steatosis. Several existing obesity treatments exhibit limited efficacy, undesirable side effects...
4.
Corral-Sarasa J, Martinez-Galvez J, Gonzalez-Garcia P, Wendling O, Jimenez-Sanchez L, Lopez-Herrador S, et al.
Cell Rep
. 2024 May;
43(5):114148.
PMID: 38697100
Coenzyme Q (CoQ) deficiency syndrome is conventionally treated with limited efficacy using exogenous CoQ. Poor outcomes result from low absorption and bioavailability of CoQ and the clinical heterogenicity of the...
5.
Barata L, de Hoz-Rivera M, Romero A, Martinez M, Silva L, Villa M, et al.
Front Pharmacol
. 2022 Aug;
13:925740.
PMID: 35924056
Hypoxic-ischemic (HI) insults have important deleterious consequences in newborns, including short-term morbidity with neuromotor and cognitive disturbances. Cannabidiol (CBD) has demonstrated robust neuroprotective effects and shows anxiolytic/antidepressant effects as well....
6.
Ouro A, Wong T, Jimenez-Sanchez L
Front Synaptic Neurosci
. 2022 Jul;
14:952564.
PMID: 35903421
No abstract available.
7.
Gonzalez-Garcia P, Diaz-Casado M, Hidalgo-Gutierrez A, Jimenez-Sanchez L, Bakkali M, Barriocanal-Casado E, et al.
Redox Biol
. 2022 Jul;
55:102403.
PMID: 35863266
Defects in Coenzyme Q (CoQ) metabolism have been associated with primary mitochondrial disorders, neurodegenerative diseases and metabolic conditions. The consequences of CoQ deficiency have not been fully addressed, and effective...
8.
Ceprian M, Vargas C, Garcia-Toscano L, Penna F, Jimenez-Sanchez L, Achicallende S, et al.
Front Pharmacol
. 2019 Oct;
10:1131.
PMID: 31611802
Neonatal hypoxia-ischemia (HI) is a risk factor for myelination disturbances, a key factor for cerebral palsy. Cannabidiol (CBD) protects neurons and glial cells after HI insult in newborn animals. We...
9.
Lopez-Gil X, Jimenez-Sanchez L, Campa L, Castro E, Frago C, Adell A
ACS Chem Neurosci
. 2019 Jun;
10(7):3318-3326.
PMID: 31244055
Depression is a chronic and debilitating illness that interferes severely with many human behaviors, and is the leading cause of disability in the world. There is data suggesting that deficits...
10.
Barata L, Cabanas A, Lafuente H, Vargas C, Ceprian M, Campa L, et al.
Pediatr Res
. 2019 Jan;
85(4):539-545.
PMID: 30675020
Background: Newborn pigs offer theoretical advantages for studying newborn hypoxic-ischemic (HI) brain damage because of a development and structure similar to the human brain. However, the correlation between functional features...